# Temsirolimus In Phase 0

> **NCT01417065** · EARLY_PHASE1 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 15 (actual)

## Conditions studied

- Advanced Cancer

## Interventions

- **DRUG:** Temsirolimus

## Key facts

- **NCT ID:** NCT01417065
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2014-06
- **Final completion:** —
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2014-06-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01417065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01417065, "Temsirolimus In Phase 0". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01417065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*